Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.Start Printed Page 51465
Table 1—List of Information Collections Approved by OMB
|Title of collection||OMB control number||Date approval
|New Animal Drugs for Investigational Use||0910-0117||8/31/2021|
|Guidance for Industry and FDA Staff, Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle||0910-0594||8/31/2021|
|Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements||0910-0608||8/31/2021|
|Prescription Drug Advertisements||0910-0686||8/31/2021|
|Survey of the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Foodservice Facility Types||0910-0744||8/31/2021|
|Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products||0910-0759||8/31/2021|
|Food and Cosmetic Export Certificate Applications Process||0910-0793||8/31/2021|
|Guidance for Industry: Medical Product Communications That are Consistent With the Food and Drug Administration Required Labeling—Questions and Answers||0910-0856||8/31/2021|
|Guidance for Industry: Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities Questions and Answers||0910-0857||8/31/2021|
|Guidance for Industry: Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies, Federal Facilities, and Certain Other Entities||0910-0858||8/31/2021|
|Drug Supply Chain Security Act Pilot Program||0910-0859||8/31/2021|
|Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Institutional and Retail Food Stores and Facility Types (2015-2025)||0910-0799||9/30/2021|
End Supplemental Information
Dated: October 4, 2018.
Associate Commissioner for Policy.
[FR Doc. 2018-22101 Filed 10-10-18; 8:45 am]
BILLING CODE 4164-01-P